AXON Forecast



Bearish   ↔   Bullish



80% Confidence




Bullish Case: Helium's model is +5.96% bullish at $414.6, with market density peaking right at spot ($415, 0.0544) and Helium's distribution carrying less downside mass below $390 than market-implied pricing. After a -32% two-month flush, valuation has reset; software mix, $14B+ backlog, and Flock/privacy-driven vendor switching remain intact. Market IV (100% Nov 7) exceeds Helium (88.7%), implying overpriced fear near-term.




Bearish Case: Put volume runs 93% above calls and Helium's bullish-risk edge is exactly zero across tenors — no model conviction. The stock is -43.7% YoY below its 200-day MA at 9.2x book; Fusus/ALPR surveillance scrutiny (Wyden/HIDTA, ACLU pressure) threatens federal renewals. Near-term IV at 78-100% prices real event risk into November, and the return surface shows fat left tails below $350.




Potential Outcomes:
  1. Rangebound $390–$445 (40%) — term structure flattens, IV decays post-Nov 7; falsified by a close outside the band by mid-December.
  2. Recovery $445–$490 (22%) — privacy backlash drives Flock-to-Axon switches; confirm with Nov IV dropping below 75% and call IV < put IV.
  3. Slip $350–$390 (23%) — renewal loss or hearing headline; confirm with front put IV >85% and price <$390.
  4. De-rating to $280–$350 (10%) — regulatory escalation plus soft guidance into Q4 earnings (~late Feb).
  5. Tail crash <$280 (5%) — federal contract action; realized vol >100%.



October 24, 2026















See risk, trade-offs, and measured results before you decide.